Cormorant Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History

Cormorant Asset Management’s Portfolio SPRY Stock Details SPRY Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$19.2M	Sell
2025 Q1	$20.1M	Buy
2024 Q4	$5.28M	Buy
2021 Q3	–	Sell
2021 Q2	$7.39M	Sell
2021 Q1	$21.8M	Hold
2020 Q4	$23.2M	Buy